Invisible Planets : Collected Fiction

Mindblowingly inventive and beautifully written short stories from the most exciting new name in SF

Hannu Rajaniemi exploded onto the SF scene in 2010 with the publication of his first novel The Quantum Thief. Acclaimed by fellow authors such as Charles Stross, Adam Roberts and Alastair Reynolds and brilliantly reviewed everywhere from Interzone to the Times and the Guardian he swiftly established a reputation as an author who could combine extraordinary cutting edge science with beautiful prose and deliver it all with wit, warmth and a delight in the fun of storytelling.

It is exactly these qualities that are showcased in this his first collection of short stories. Drawn from antholgies, magazines and online publications and brought together in book form for the first time in this collection here is a collection of seventeen short stories that range from the lyrical to the bizarre, from the elegaic to the impish. It is a collection that shows one of the great new imaginations in SF having immense fun.

Hannu Rajaniemi was born in Finland. At the age of eight he approached the European Space Agency with a fusion-powered spaceship design, which was received with a polite "thank you" note. Hannu studied mathematics and theoretical physics at University of Oulu and Cambridge and holds a PhD in string theory from the University of Edinburgh. He co-founded a mathematics consultancy whose clients included UK Ministry of Defence and the European Space Agency.

Hannu is the author of four novels including The Quantum Thief (winner of 2012 Tähtivaeltaja Award for the best science fiction novel published in Finland and translated into more than 20 languages). His most recent book is Summerland (June 2018), an alternate history spy thriller in a world where the afterlife is real. His other works include Invisible Planets: Collected Fiction, a short story collection.

Hannu lives in the San Francisco Bay Area. He is a co-founder and CEO of HelixNano, a venture- and Y Combinator backed biotech startup.